Clinical Trial Technology Editorial

  1. 4 Perspectives On What's Next In Clinical Trial Tech 12/12/2024

    Clinical Leader asked clinical research professionals: “Internal, external, patient-facing, or otherwise — what clinical trial tech tool are you most excited to embrace or ditch in the new year? And why?”

  2. How Did Clinical Researchers Actually Use AI In 2024? 12/5/2024

    Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”

  3. Pondering The "What Ifs" Of Inspection Readiness With Generative AI 12/4/2024

    Just In Time GCP Founder and CEO Donna Dorozinsky contemplates some of the developing uses of generative AI for inspection readiness.

  4. What's Trending In Medical Devices And Diagnostics For 2025? 12/4/2024

    Four program directors from the Medical Device Innovation Consortium (MDIC) share their predictions on the trends that will drive innovation and reshape clinical research in 2025.

  5. A Data-Driven Approach That Could Change Mental Healthcare In 2025… And Beyond 12/2/2024

    Heterogeneity of patient populations combined with subjective clinical interpretation often results in imprecise treatments, frustrated patients, and poor outcomes, says Greg Hajcak, Ph.D. Here, he argues for a data-driven approach, also called “precision psychiatry,” to personalize clinical trials and care.

  6. Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research 11/27/2024

    Consultants Aashna Goyal and Guriqbal Singh share first-persona accounts of how AI is transforming pharmacovigilance and clinical research by improving data processing, enhancing decision-making, and accelerating drug development.

  7. Plodding Toward Better Data Integration & SSO 10/23/2024

    Laura Hilty, a principal at HealthX Ventures, talks about the need to better integrate data platforms and improve/enable single sign-on (SSO) solutions so sites can lessen their administrative burden.

  8. AI's Potential Must Reconcile With R&D And Regulatory Bottlenecks 10/11/2024

    Evaluate's Daniel Chancellor explains that by working together to expand AI resources and adapt regulatory frameworks, the FDA and others can ensure the benefits of AI are fully realized while maintaining high standards of safety and efficacy.

  9. DPHARM 2024 Highlights ClinOps Innovations That Address Cost, Complexity, & Capabilities 10/1/2024

    The 14th annual DPHARM conference included sessions ranging from the ROI of DCTs to how and where to innovate in a resource-constrained environment. In this article, we give some of the highlights from this informative annual event.

  10. AI Can't Help Bad ClinOps/Health Equity Data 9/25/2024

    Brian Johnson, Ph.D., VP, R&D Technology at Takeda discusses the huge opportunity of connecting disparate ClinOps data and leveraging generative AI to reduce costs and labor during the clinical process.